Bank of America’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-1,900
| Closed | -$16K | – | 7675 |
|
|
2018
Q2 | $16K | Sell |
1,900
-17,455
| -90% | -$157K | ﹤0.01% | 6575 |
|
|
2018
Q1 | $196K | Buy |
19,355
+579
| +3% | +$4.86K | ﹤0.01% | 5377 |
|
|
2017
Q4 | $91K | Hold |
18,776
| – | – | ﹤0.01% | 5787 |
|
|
2017
Q3 | $86K | Buy |
18,776
+1,561
| +9% | +$7.33K | ﹤0.01% | 5732 |
|
|
2017
Q2 | $87K | Sell |
17,215
-131
| -0.8% | -$586 | ﹤0.01% | 5658 |
|
|
2017
Q1 | $82K | Sell |
17,346
-1,341
| -7% | -$6.77K | ﹤0.01% | 5714 |
|
|
2016
Q4 | $105K | Sell |
18,687
-1,496
| -7% | -$8.21K | ﹤0.01% | 5604 |
|
|
2016
Q3 | $112K | Buy |
20,183
+61
| +0.3% | +$403 | ﹤0.01% | 5386 |
|
|
2016
Q2 | $141K | Buy |
20,122
+1,666
| +9% | +$11.7K | ﹤0.01% | 5376 |
|
|
2016
Q1 | $122K | Buy |
18,456
+17,019
| +1,184% | +$125K | ﹤0.01% | 5383 |
|
|
2015
Q4 | $15K | Buy |
1,437
+1,220
| +562% | +$14.1K | ﹤0.01% | 6541 |
|
|
2015
Q3 | $3K | Hold |
217
| – | – | ﹤0.01% | 6928 |
|
|
2015
Q2 | $2K | Sell |
217
-943
| -81% | -$7.12K | ﹤0.01% | 7077 |
|
|
2015
Q1 | $7K | Sell |
1,160
-1,188
| -51% | -$7.35K | ﹤0.01% | 6428 |
|
|
2014
Q4 | $13K | Hold |
2,348
| – | – | ﹤0.01% | 6979 |
|
|
2014
Q3 | $14K | Buy |
2,348
+500
| +27% | +$3.05K | ﹤0.01% | 7212 |
|
|
2014
Q2 | $12K | Buy |
1,848
+131
| +8% | +$877 | ﹤0.01% | 7400 |
|
|
2014
Q1 | $13K | Sell |
1,717
-42
| -2% | -$290 | ﹤0.01% | 7109 |
|
|
2013
Q4 | $12K | Buy |
1,759
+42
| +2% | +$286 | ﹤0.01% | 7239 |
|
|
2013
Q3 | $13K | Buy |
+1,717
| New | +$11.6K | ﹤0.01% | 7084 |
|
Bank of America's JNP Position: Q3 2018 in Review
Bank of America sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q3 2018, closing a stake of 1,900 shares — an estimated $16K sold.
Bank of America first reported a position in JNP in Q3 2013 and held it in 20 quarters. The position peaked at $196K in Q1 2018. 0 funds tracked by Wall St. Rank hold JNP as of Q3 2018.
- Bank of America reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
- Bank of America sold 1,900 Juniper Pharmaceuticals, Inc. Common Stock shares in Q3 2018, an estimated $16K.
- Bank of America first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q3 2013 and held it in 20 quarters.
- Bank of America's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $196K in Q1 2018.
- 0 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q3 2018.
Based on Bank of America's 13F filing for Q3 2018, filed 14 Nov 2018.